Small-Molecule Inhibitors Disrupt let-7 Oligouridylation and Release the Selective Blockade of let-7 Processing by LIN28

Longfei Wang, R. Grant Rowe, Adriana Jaimes, Chunxiao Yu, Yunsun Nam, Daniel S. Pearson, Jin Zhang, Xiangyu Xie, William Marion, Gregory J. Heffron, George Q. Daley, Piotr Sliz

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

LIN28 is an RNA-binding protein that regulates the maturation of the let-7 family of microRNAs by bipartite interactions with let-7 precursors through its two distinct cold shock and zinc-knuckle domains. Through inhibition of let-7 biogenesis, LIN28 functions as a pluripotency factor, as well as a driver of tumorigenesis. Here, we report a fluorescence polarization assay to identify small-molecule inhibitors for both domains of LIN28 involved in let-7 interactions. Of 101,017 compounds screened, six inhibit LIN28:let-7 binding and impair LIN28-mediated let-7 oligouridylation. Upon further characterization, we demonstrate that the LIN28 inhibitor TPEN destabilizes the zinc-knuckle domain of LIN28, while LI71 binds the cold shock domain to suppress LIN28’s activity against let-7 in leukemia cells and embryonic stem cells. Our results demonstrate selective pharmacologic inhibition of individual domains of LIN28 and provide a foundation for therapeutic inhibition of the let-7 biogenesis pathway in LIN28-driven diseases. LIN28 is an oncogenic protein that promotes transformation in malignancy by suppressing the maturation of let-7 microRNAs. Wang et al. developed a high-throughput screening strategy and identified inhibitors of LIN28 that restore mature let-7 levels.

Original languageEnglish (US)
Pages (from-to)3091-3101
Number of pages11
JournalCell Reports
Volume23
Issue number10
DOIs
StatePublished - Jun 5 2018

Fingerprint

MicroRNAs
Zinc
Shock
Molecules
Fluorescence Polarization
RNA-Binding Proteins
Embryonic Stem Cells
Processing
Stem cells
Assays
Screening
Carcinogenesis
Leukemia
Fluorescence
Throughput
Polarization
Neoplasms
Proteins
Therapeutics
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine

Keywords

  • 5-(methylamino)nicotinic acid
  • let-7
  • LI71
  • LIN28
  • LIN28 inhibitor
  • oligouridylation
  • pre-let-7
  • TPEN
  • TUT4
  • TUTase

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Small-Molecule Inhibitors Disrupt let-7 Oligouridylation and Release the Selective Blockade of let-7 Processing by LIN28. / Wang, Longfei; Rowe, R. Grant; Jaimes, Adriana; Yu, Chunxiao; Nam, Yunsun; Pearson, Daniel S.; Zhang, Jin; Xie, Xiangyu; Marion, William; Heffron, Gregory J.; Daley, George Q.; Sliz, Piotr.

In: Cell Reports, Vol. 23, No. 10, 05.06.2018, p. 3091-3101.

Research output: Contribution to journalArticle

Wang, L, Rowe, RG, Jaimes, A, Yu, C, Nam, Y, Pearson, DS, Zhang, J, Xie, X, Marion, W, Heffron, GJ, Daley, GQ & Sliz, P 2018, 'Small-Molecule Inhibitors Disrupt let-7 Oligouridylation and Release the Selective Blockade of let-7 Processing by LIN28', Cell Reports, vol. 23, no. 10, pp. 3091-3101. https://doi.org/10.1016/j.celrep.2018.04.116
Wang, Longfei ; Rowe, R. Grant ; Jaimes, Adriana ; Yu, Chunxiao ; Nam, Yunsun ; Pearson, Daniel S. ; Zhang, Jin ; Xie, Xiangyu ; Marion, William ; Heffron, Gregory J. ; Daley, George Q. ; Sliz, Piotr. / Small-Molecule Inhibitors Disrupt let-7 Oligouridylation and Release the Selective Blockade of let-7 Processing by LIN28. In: Cell Reports. 2018 ; Vol. 23, No. 10. pp. 3091-3101.
@article{0a10ac2f54384d46b9ce6bdff4d187e5,
title = "Small-Molecule Inhibitors Disrupt let-7 Oligouridylation and Release the Selective Blockade of let-7 Processing by LIN28",
abstract = "LIN28 is an RNA-binding protein that regulates the maturation of the let-7 family of microRNAs by bipartite interactions with let-7 precursors through its two distinct cold shock and zinc-knuckle domains. Through inhibition of let-7 biogenesis, LIN28 functions as a pluripotency factor, as well as a driver of tumorigenesis. Here, we report a fluorescence polarization assay to identify small-molecule inhibitors for both domains of LIN28 involved in let-7 interactions. Of 101,017 compounds screened, six inhibit LIN28:let-7 binding and impair LIN28-mediated let-7 oligouridylation. Upon further characterization, we demonstrate that the LIN28 inhibitor TPEN destabilizes the zinc-knuckle domain of LIN28, while LI71 binds the cold shock domain to suppress LIN28’s activity against let-7 in leukemia cells and embryonic stem cells. Our results demonstrate selective pharmacologic inhibition of individual domains of LIN28 and provide a foundation for therapeutic inhibition of the let-7 biogenesis pathway in LIN28-driven diseases. LIN28 is an oncogenic protein that promotes transformation in malignancy by suppressing the maturation of let-7 microRNAs. Wang et al. developed a high-throughput screening strategy and identified inhibitors of LIN28 that restore mature let-7 levels.",
keywords = "5-(methylamino)nicotinic acid, let-7, LI71, LIN28, LIN28 inhibitor, oligouridylation, pre-let-7, TPEN, TUT4, TUTase",
author = "Longfei Wang and Rowe, {R. Grant} and Adriana Jaimes and Chunxiao Yu and Yunsun Nam and Pearson, {Daniel S.} and Jin Zhang and Xiangyu Xie and William Marion and Heffron, {Gregory J.} and Daley, {George Q.} and Piotr Sliz",
year = "2018",
month = "6",
day = "5",
doi = "10.1016/j.celrep.2018.04.116",
language = "English (US)",
volume = "23",
pages = "3091--3101",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "10",

}

TY - JOUR

T1 - Small-Molecule Inhibitors Disrupt let-7 Oligouridylation and Release the Selective Blockade of let-7 Processing by LIN28

AU - Wang, Longfei

AU - Rowe, R. Grant

AU - Jaimes, Adriana

AU - Yu, Chunxiao

AU - Nam, Yunsun

AU - Pearson, Daniel S.

AU - Zhang, Jin

AU - Xie, Xiangyu

AU - Marion, William

AU - Heffron, Gregory J.

AU - Daley, George Q.

AU - Sliz, Piotr

PY - 2018/6/5

Y1 - 2018/6/5

N2 - LIN28 is an RNA-binding protein that regulates the maturation of the let-7 family of microRNAs by bipartite interactions with let-7 precursors through its two distinct cold shock and zinc-knuckle domains. Through inhibition of let-7 biogenesis, LIN28 functions as a pluripotency factor, as well as a driver of tumorigenesis. Here, we report a fluorescence polarization assay to identify small-molecule inhibitors for both domains of LIN28 involved in let-7 interactions. Of 101,017 compounds screened, six inhibit LIN28:let-7 binding and impair LIN28-mediated let-7 oligouridylation. Upon further characterization, we demonstrate that the LIN28 inhibitor TPEN destabilizes the zinc-knuckle domain of LIN28, while LI71 binds the cold shock domain to suppress LIN28’s activity against let-7 in leukemia cells and embryonic stem cells. Our results demonstrate selective pharmacologic inhibition of individual domains of LIN28 and provide a foundation for therapeutic inhibition of the let-7 biogenesis pathway in LIN28-driven diseases. LIN28 is an oncogenic protein that promotes transformation in malignancy by suppressing the maturation of let-7 microRNAs. Wang et al. developed a high-throughput screening strategy and identified inhibitors of LIN28 that restore mature let-7 levels.

AB - LIN28 is an RNA-binding protein that regulates the maturation of the let-7 family of microRNAs by bipartite interactions with let-7 precursors through its two distinct cold shock and zinc-knuckle domains. Through inhibition of let-7 biogenesis, LIN28 functions as a pluripotency factor, as well as a driver of tumorigenesis. Here, we report a fluorescence polarization assay to identify small-molecule inhibitors for both domains of LIN28 involved in let-7 interactions. Of 101,017 compounds screened, six inhibit LIN28:let-7 binding and impair LIN28-mediated let-7 oligouridylation. Upon further characterization, we demonstrate that the LIN28 inhibitor TPEN destabilizes the zinc-knuckle domain of LIN28, while LI71 binds the cold shock domain to suppress LIN28’s activity against let-7 in leukemia cells and embryonic stem cells. Our results demonstrate selective pharmacologic inhibition of individual domains of LIN28 and provide a foundation for therapeutic inhibition of the let-7 biogenesis pathway in LIN28-driven diseases. LIN28 is an oncogenic protein that promotes transformation in malignancy by suppressing the maturation of let-7 microRNAs. Wang et al. developed a high-throughput screening strategy and identified inhibitors of LIN28 that restore mature let-7 levels.

KW - 5-(methylamino)nicotinic acid

KW - let-7

KW - LI71

KW - LIN28

KW - LIN28 inhibitor

KW - oligouridylation

KW - pre-let-7

KW - TPEN

KW - TUT4

KW - TUTase

UR - http://www.scopus.com/inward/record.url?scp=85047806341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047806341&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2018.04.116

DO - 10.1016/j.celrep.2018.04.116

M3 - Article

C2 - 29874593

AN - SCOPUS:85047806341

VL - 23

SP - 3091

EP - 3101

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 10

ER -